down arrow

Beta Drugs Ltd

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE351Y01019
  • NSEID: BETA
  • BSEID:
  • View on NSE
INR
1,402.40
33.7 (2.46%)
BSENSE

May 26

BSE+NSE Vol: 23488

Access older stock analysis version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Net Sales
290.86
Other Operating Income
0.00
Total Operating income
290.86
Raw Material Cost
137.03
Purchase of Finished goods
0.00
(Increase) / Decrease In Stocks
-1.95
Employee Cost
36.05
Power Cost
0.00
Manufacturing Expenses
25.15
Selling and Distribution Expenses
0.00
Other Expenses
36.58
Total Expenditure (Excl Depreciation)
232.86
Operating Profit (PBDIT) excl Other Income
58.00
Other Income
8.29
Operating Profit (PBDIT)
66.29
Interest
11.36
Exceptional Items
0.00
Gross Profit (PBDT)
54.93
Depreciation
12.36
Profit Before Tax
42.56
Tax
10.12
Provisions and contingencies
0.00
Profit After Tax
32.44
Extraordinary Items
0.00
Prior Period Expenses
0.00
Other Adjustments
0.00
Net Profit
32.44
Share in Profit of Associates
0.00
Minority Interest
0.00
Other related items
0.00
Consolidated Net Profit
32.44
Equity Capital
10.14
Face Value
10.0
Reserves
0.00
Diluted Earnings per share
8.4
Operating Profit Margin (Excl OI)
19.94%
Gross Profit Margin
18.89%
PAT Margin
11.15%
Public Share Holdings (%)
0.0%
Pledged Promotor Holding (%)
0.0%
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 6.05% vs 16.59% in Mar 2026

stock-summary

Consolidate Net Profit

YoY Growth in nine months ended Dec 2025 is -3.14% vs 15.80% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is 2.69% vs 11.75% in Mar 2026

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is 96.88% vs 8.66% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has fallen from Mar 2026

Compare Nine Monthly Results Of Beta Drugs Ltd With
Markets Mojo
Figures in Cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
290.86
0
290.86
Other Operating Income
0.00
0.00
0.00
Total Operating income
290.86
0
290.86
Raw Material Cost
137.03
0
137.03
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
-1.95
0
-1.95
Employee Cost
36.05
0
36.05
Power Cost
0.00
0
0.00
Manufacturing Expenses
25.15
0
25.15
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
36.58
0.00
36.58
Total Expenditure (Excl Depreciation)
232.86
0
232.86
Operating Profit (PBDIT) excl Other Income
58.00
0.00
58.00
Other Income
8.29
0
8.29
Operating Profit (PBDIT)
66.29
0
66.29
Interest
11.36
0
11.36
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
54.93
0
54.93
Depreciation
12.36
0
12.36
Profit Before Tax
42.56
0
42.56
Tax
10.12
0
10.12
Provisions and contingencies
0.00
0
0.00
Profit After Tax
32.44
0
32.44
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
32.44
0
32.44
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
32.44
0
32.44
Equity Capital
10.14
0
10.14
Face Value
10.00
0
0.00
Reserves
0.00
0
0.00
Gross Profit Margin
18.89%
0%
0.00
18.89%
PAT Margin
11.15%
0%
0.00
11.15%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 290.86 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 6.05% vs 16.59% in Mar 2026

Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 32.44 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is -3.14% vs 15.80% in Mar 2026

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 58.00 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 2.69% vs 11.75% in Mar 2026

Nine Monthly - Interest
Interest 11.36 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 96.88% vs 8.66% in Mar 2026

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.94%
in Dec 2025

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2025 has fallen from Mar 2026

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Download on App Store
Get it on Google Play
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."